ecancer
B

2020 ESMO Updates on Stage 4 GU Cancers: Olaparib in CRPC, Ipatasertib + Abiraterone + Prednisone / Prednisolone in CRPC, 1L Nivo + Cabozantinib in RCC, Durvalumab +/- Tremelimumab vs. Chemo in UC

By ecancer FEATURING Bishal Gyawali
By ecancer FEATURING Bishal Gyawali
444 views
January 5, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

21:17
Janssen Oncology

The Man Cave

Feat. J. Hamilton, M. Fabrizio, M. Taha

Featured Video

20:25
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Related Content

AUTOPLAY
11:56
Ana Aparicio

Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment…

14:16
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Mes…

Feat. E. Efstathiou
09:14
Robert Dreicer

AUA Advanced Prostate Cancer Guidelines: 2023 Update

13:37
SIR 2023 Conference Coverage

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

Feat. N. Kothary
16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
27:04
Fengting Yan

Cancer Screening Molecular Tools

15:58
Total Health

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Feat. M. Reimers
05:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare …

Feat. S. Tagawa
22:19
Insights from 2023 ESMO Annual Meeting

Bladder Cancer Highlights From ESMO 2023: Comparing and Contrasting …

Feat. G. Sonpavde
08:05
Total Health

Prostate Cancer Updates From ASCO® 2023

Feat. T. Zhang
11:39
Oncology Data Advisor

Recent Prostate Cancer Updates

Feat. U. Vaishampayan
21:17
Manish Kohli

Time to Castrate Resistance in mCSPC Using Standard of Care Intensif…

19:07
Stanford Medicine

Stanford Medicine Advances in Imaging to Improve Prostate Cancer Dia…

Feat. G. Sonn
09:45
Northwestern Medicine Oncology and Hematology

Differences Between Urologists and Medical Oncologists in the Manage…

Feat. W. Catalona
07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

19:41
Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

25:33
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute Prostate Cancer Updates From ASCO GU 20…

Feat. J. Berchuck, A. Choudhury
14:00
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Key Highlights in Bladder/Urothelial Ca…

Feat. G. Sonpavde
12:39
ASCO GU 2023 Conference Coverage

Efficacy and Safety of Darolutamide in Combination With ADT and Doce…

Feat. C. Sternberg
06:01
ecancer

ESMO 2023 Insights: "Phase 3 EV-302 Trial - Evaluating the Comb…

Feat. T. Powles